A major international collaboration led by Melbourne researchers has discovered that the world’s most widespread malaria parasite infects humans by hijacking a protein the body cannot live without.
The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
The study, led by the Walter and Eliza Hall Institute’s Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, found that the deadly malaria parasite Plasmodium vivax (P. vivax) causes infection through latching onto the human transferrin receptor protein, which is crucial for iron delivery into the body’s young red blood cells.
Published today in Science, the discovery has solved a mystery that researchers have been grappling with for decades.
Associate Professor Tham, who is also a HHMI-Wellcome International Research Scholar, said the collective efforts of teams from Australia, New Zealand, Singapore, Thailand, United Kingdom, United States, Brazil and Germany had brought the world closer to a potential effective vaccine against P.vivax malaria.
“P. vivax currently inflicts a huge burden on global health. It is the most common malaria parasite in countries outside of Africa, with more than 16 million clinical cases recorded each year.
“The parasite can lie dormant in the liver for months on end without causing any symptoms, which makes it very sneaky and difficult to treat,” Associate Professor Tham said.
“We now know that P. vivax is hijacking the human transferrin receptor which is essential for transporting iron into the body’s young red blood cells.
“Being able to stop P. vivax from latching onto this receptor and infliltrating the blood is a major breakthrough and important step towards malaria elimination,” she said.
Dr Gruszczyk said once the teams understood how the parasite was gaining entry into the cells, they were able to design antibodies to block the mode of access.
“Using the Australian Synchrotron in Melbourne, we generated a 3D map of the parasite protein which is the mechanism P. vivax uses to latch onto the human transferrin receptor and enter the young red blood cells.
“This map provided an unprecedented view of the parasite protein’s shape, which guided the design of antibodies to block P. vivax from gaining entry into the human cells,” Dr Gruszczyk said.
Associate Professor Tham said they were thrilled to see the antibodies successfully block P. vivax invasion using parasites from both Thailand and Brazil. “We are now looking to include collaborative partners in the Pacific, so we can further test the effectiveness of our antibodies,” she said.
Study collaborator Dr Jonathan Abraham from Harvard University said the results of the new study aligned with a growing body of evidence that could be used to target multiple infectious diseases.
“Transferrin receptor is also co-opted by five viruses that cause Ebola-like diseases in South America. These diseases are known as New World haemorrhagic fevers.
“Our increasing understanding of how several pathogens are taking advantage of transferrin receptor, means we are getting closer to disrupting infection for a number of deadly diseases,” Dr Abraham said.
The Latest on: Malaria parasite
- Preventing malaria in pregnancy: Need for regular supply of Sulphadoxine –Pyrimethamineon February 26, 2021 at 7:18 pm
It has been the case that some pregnant women would not report for antenatal care (ANC) when they got pregnant so that they would be put on malaria prevention treatment to protect themselves and their ...
- The World Health Organization says El Salvador has eliminated malariaon February 25, 2021 at 4:12 pm
El Salvador on Thursday became the first country in Central America to be certified malaria-free by the World Health Organization.Why it matters: It's the 38th country to eliminate the parasitic ...
- Lethal house lures reduce incidence of malaria in childrenon February 25, 2021 at 3:34 pm
A new type of housing modification can reduce malaria incidence among children by around 40-50%, according to an international team of researchers. The intervention uses window screening, together ...
- Research addresses the complex problems of malariaon February 24, 2021 at 7:04 am
According to Childs' team's study, while a mosquito ingests the parasite in a ''blood meal'' by biting an infected person, it typically takes about 10 to 14 days -- known as the ''extrinsic incubation ...
- World's largest resource of genome variation data on malaria parasites releasedon February 24, 2021 at 5:20 am
Genome variation data on more than 7,000 malaria parasites from 28 endemic countries is released today (24 February) in Wellcome Open Research.
- Nigeria: Drug-Resistant Malaria - a Public Health War Nigeria Cannot Afford to Fighton February 24, 2021 at 4:59 am
In today's Thought Leadership Piece, Dr. Okonkwor Oyor of Hygeia HMO explains the looming threat that ACT-resistant malaria poses to the long global struggle to "roll back malaria", and shares ...
- Open data on malaria genomes will help combat drug resistanceon February 24, 2021 at 2:32 am
Genome variation data on more than 7,000 malaria parasites from 28 endemic countries is released today in Wellcome Open Research. It has been produced by MalariaGEN, a data-sharing network of groups ...
- Malaria, the bitter experiences, and the realitieson February 23, 2021 at 7:59 pm
Many children in Ghana die before the age of five, due to complications from malaria, the story of Madam Yaa Rose, ( not real name) a 45-year-old mother of three, at Sokode Juaso, a village near ...
- 20S proteasomes secreted by the malaria parasite promote its growthon February 19, 2021 at 8:06 am
Plasmodium falciparum secretes extracellular vesicles (EVs) while growing inside red blood cells (RBCs). Here the authors show that these EVs contain assembled and functional 20S proteasome complexes ...
- Magnetic tech developed to better diagnose malariaon February 18, 2021 at 1:26 pm
It can be difficult to determine if someone has malaria – enough so, that many people who don't even have the disease end up being treated for it. A new technique, however, could make diagnosis much ...
via Google News and Bing News